Advanced Biomed Cash Flow Statement (2023-2026) | ADVB

Cash Flow Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.15M-1.06M-0.81M-0.27M-0.33M-0.19M-1.50M-0.39M-0.14M
Depreciation and Depletion (Quarter) 0.06M0.05M0.12M0.07M0.02M0.02M0.16M0.05M0.01M0.01M
Cash from Discontinued Operations (Quarter) 2.03M
Cash from Operations (Quarter) -1.07M-0.48M-0.03M-0.44M-5.44M0.09M-0.61M0.36M-0.24M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.06M0.08M0.15M0.10M-0.06M0.02M0.28M0.05M-0.01M0.01M
Change in Working Capital
Change in Accured Expenses (Quarter) -0.08M0.18M0.17M-0.13M-2.21M2.06M-0.23M-0.10M0.04M
Other Working Capital Changes (Quarter) 0.00M-312.00-246.00-0.03M0.01M
Investing Activities
Capital Expenditures (Quarter) -0.03M-0.08M0.02M-0.01M0.00M0.07M-0.01M0.02M0.00M
Cash from Investing Activities (Quarter) 0.03M-0.05M-0.02M0.01M-0.00M-0.02M-0.00M-0.01M-0.00M
Financing Activities
Other financing activities (Quarter) -0.02M-0.02M0.37M5.16M6.56M-5.92M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.85M0.34M0.21M0.30M0.05M-0.47M0.01M0.13M0.00M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.20M
Misc.
Cash from Financing Activities (Quarter) 0.56M0.32M0.39M0.41M5.56M-0.43M0.45M-0.33M0.91M
Exchange Rate Effect (Quarter) 0.36M0.15M-0.30M0.37M0.07M0.08M-0.08M-0.04M-0.03M
Change in Cash (Quarter) -0.11M-0.06M0.04M0.01M2.53M-2.28M-0.25M-0.05M-0.00M
Free Cash Flow (Quarter) -1.04M-0.40M-0.05M-0.43M-5.44M0.02M-0.60M0.34M-0.24M
Net Cash Flow (Quarter) -0.48M-0.21M0.34M-0.03M0.12M-0.36M-0.16M0.02M0.67M